The expression of these genes in gastric cancer inversely correlates with the expression of HOXA11-AS, which is required for their silencing favouring the binding and activity of PRC2, LSD1, and DNMT1 on their promoters [33]. The gene discussed is HOXA11; the disease is gastric cancer.